Leukemia Current Events | Leukemia News | 10
|
| Page
10 of
10 |
196 Results |
|
|
|
Sort By:
Page Views | Date |
Cancer drug may be remedy for rheumatoid arthritis, Stanford study finds
The potent cancer drug Gleevec, used to combat leukemia and some gastrointestinal cancers, may be useful in treating rheumatoid arthritis. view more (2006-09-29)
Discoveries thrust cancer-initiating stem cells into a larger role in cancer biology and treatment
Recent discoveries about the role of stem cells in cancer have altered the landscape of cancer research. With each new study, scientists are learning more about cancer-initiating properties of stem cells at organ sites and throughout the body. view more (2007-04-19)
'Corrective genes' closer thanks to enzyme modification
Scientists from the Université de Montréal and McGill University have re-engineered a human enzyme, a protein that accelerates chemical reactions within the human body, to become highly resistant to harmful agents such as chemotherapy, according to a new study published in The Journal of Biological Chemistry. view more (2009-07-29)
T vs. B: Re-engineered human T cells effectively target and kill cancerous B cells
Human white blood cells, engineered to recognize other malignant immune cells, could provide a novel therapy for patients with highly lethal B cell cancers such as acute lymphoblastic leukemia (ALL), according to researchers at Memorial Sloan-Kettering Cancer Center (MSKCC). view more (2007-09-18)
Study of leukemia survivors gives hints for better care
Results from the longest follow-up study ever done of childhood acute lymphoblastic leukemia (ALL) survivors show the importance of long-term monitoring of former patients to identify complications they are at risk for developing later in life and to modify current treatments to reduce those risks. view more (2007-03-21)
Pioneering discoveries recognized in field of immune deficiencies in children (so-called bubble children)
Professor Alain Fischer from Paris is being awarded the prestigious M'Īrta Philipson Prize in Children's Medicine from Karolinska Institutet in Sweden for his research on immune deficiencies in children. Many children are particularly susceptible to infections and often contract ear inflammations, for example. Every year a few children are born... view more... (2003-01-27)
Transplantation Society Awards Prestigious Medawar Prize
MIAMI, Aug. 29 - At the XIX International Congress of The Transplantation Society, three distinguished physician-scientists were named as the winners of the 2002 Medawar Prize. Those recognized by The Transplantation Society for their outstanding contributions to the field of transplantation were Georges Mathé, M.D., René Küss,... view more... (2002-08-29)
The good and bad side of anti-cancer compounds
Compounds known as "HDAC inhibitors" exhibit cancer-killing activities in cultured cells. While they are currently being tested as anti-cancer agents in clinical trials, just how they execute their effects is unclear. view more (2008-04-11)
Protection against cancer may begin during pregnancy
There may be another reason for pregnant and nursing women to eat a nutritious diet that includes generous amounts of cruciferous vegetables like broccoli and cabbage - it could help protect their children from cancer, both as infants and later in life. view more (2006-12-26)
UBC research finds molecular
University of British Columbia researchers have discovered a "molecular key" that could help increase the success of blood stem cell transplants, a procedure currently used to treat diseases such as leukemia, Hodgkin's lymphoma and aplastic anemia. view more (2009-04-23)
UCLA researchers find blood stem cells originate and are nurtured in the placenta
Solving a long-standing biological mystery, UCLA stem cell researchers have discovered that blood stem cells, the cells that later differentiate into all the cells in the blood supply, originate and are nurtured in the placenta. view more (2008-03-06)
Tulane pioneers novel ovarian cancer treatment
The Tulane University Section of Hematology and Medical Oncology is investigating a novel treatment for ovarian cancer by using intravenous Ontak to deplete harmful cells that inhibit the body's natural immune response to fight cancer. Ovarian cancer is the fifth leading cancer killer of women in the United States. view more (2005-07-18)
Chemosensitivity of cancer cells depends on their protein dependency
Two different anti-apoptotic proteins support cancer cell survival via an identical mechanism, yet differ in their sensitivity to chemotherapeutic drugs, report Brunelle et al. The study will be published online October 26, 2009 and in the November 2, 2009 print issue of the Journal of Cell Biology (JCB). view more (2009-10-26)
Retinoblastoma researchers find success with two-drug combination
Retinoblastoma is a tumor that arises in the cells of the retina, the light-sensitive tissue at the back of the eyeball, following mutation of the gene RB1. view more (2005-10-18)
Newly Identified Gene Activated In 80% Of Breast Cancer Patients
New research, published this week in Breast Cancer Research, could provide a genetic explanation for breast cancer. A George Washington University Medical Center team, led by Patricia Berg, has discovered that the gene BP1 is activated in 80% of breast cancer patients. The researchers believe that this gene may offer a useful new target for early... view more... (2003-04-25)
Severe Sepsis Causes Almost 10% Of Cancer Deaths
Severe sepsis, is a costly complication in hospitalized cancer patients causing around one in ten cancer deaths each year in the USA, according to an article published today in Critical Care. The excessive response to infection in patients with severe sepsis injures critical organs such as the lungs and kidneys. Dr Mark Williams and his colleagues... view more... (2004-07-01)
|
|
| Page
10 of
10 |
196 Results |
|
|
|
Sort By:
Page Views | Date |
|
